Mitsuhiro Makino

Title: Mitsuhiro Makino: Innovator in Pharmaceutical Development

Introduction

Mitsuhiro Makino is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit dipeptidyl peptidase IV. With a total of two patents to his name, Makino's work is recognized for its potential impact on medical treatments.

Latest Patents

Mitsuhiro Makino's latest patents include a compound inhibiting dipeptidyl peptidase IV. This compound is characterized by its satisfactory activity, stability, and safety, making it an excellent candidate as a pharmaceutical agent. The patent describes a compound represented by a specific general formula, which includes various substituents that enhance its efficacy. Another significant patent is for a GLP-1 derivative that is absorbable via mucous membranes. This derivative includes modifications to the amino acid sequence of GLP-1, which improve its absorption efficiency and confer resistance to enzymatic degradation.

Career Highlights

Mitsuhiro Makino is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing compounds that can lead to more effective treatments for various medical conditions. His contributions are vital in advancing the understanding and application of peptide-based therapies.

Collaborations

Mitsuhiro Makino collaborates with esteemed colleagues such as Yuji Hayashi and Motohiro Takeda. Their combined expertise enhances the research and development efforts within their organization, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Mitsuhiro Makino's contributions to pharmaceutical innovation through his patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in medical treatments.